What is Nalagenetics?
Nalagenetics is a Singapore-based biotechnology enterprise specializing in pharmacogenomics. The company focuses on mitigating adverse drug reactions and enhancing prescription efficacy by providing localized genetic testing solutions tailored for Asian populations. By bridging the gap between complex genomic data and clinical application, Nalagenetics empowers physicians and patients in Singapore, Indonesia, and the broader region with actionable insights. Their platform is designed to make genetic diagnostics more accessible, affordable, and culturally relevant, positioning the company as a key player in the digital health transformation of Southeast Asian healthcare systems.
How much funding has Nalagenetics raised?
Nalagenetics has raised a total of $13.6M across 2 funding rounds:
Series A
$12.6M
Other Financing Round
$1M
Series A (2022): $12.6M with participation from Intudo Ventures and Vulcan Capital
Other Financing Round (2022): $1M led by East Ventures
Key Investors in Nalagenetics
Intudo Ventures
Intudo Ventures is a venture capital firm investing exclusively in the Indonesian digital ecosystem, combining Silicon Valley expertise with deep local networks.
East Ventures
East Ventures is a prominent Southeast Asian venture capital firm focusing on sustainable development and supporting visionary founders from Seed to Growth stages.
Vulcan Capital
Vulcan Capital is an investment firm that provides strategic capital to high-growth companies across various sectors, focusing on long-term value creation.
What's next for Nalagenetics?
With the support of major institutional backers, Nalagenetics is well-positioned to transition from its current growth phase into broader market penetration. The strategic roadmap likely involves scaling its genetic testing infrastructure and deepening its clinical partnerships to integrate genomic insights into standard medical practice. As the company leverages this recent financing, the focus will shift toward enhancing its proprietary diagnostic algorithms and expanding its footprint in emerging markets. By maintaining a rigorous commitment to localized data, Nalagenetics aims to set a new standard for precision medicine in the region, ultimately driving long-term value for both healthcare providers and the patient populations they serve.
See full Nalagenetics company page
